Nectar Lifesciences Limited has informed the Exchange regarding a press release dated July 08, 2025, titled "Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores".
Nectar Lifesciences Limited has informed the Exchange regarding a press release dated July 08, 2025, titled "Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores".